Families Bring Class-Action Suit Against Sanofi Over Epilepsy Drug Linked to Birth Effects


The AP reports a French association of about 2,900 families affected by Depakine, an epilepsy drug that caused birth defects, “launched a class action against pharmaceutical company Sanofi on Tuesday.” A study by the newspaper Le Canard Enchaine “found that Depakine was prescribed to more than 10,000 pregnant women in France between 2007 and 2014. Another report published in February estimated that around 450 children in France who were exposed to the drug while in the womb were born with congenital defects.” The class action “alleges that Sanofi failed to properly inform users about the drug’s potential risks for developing fetuses.”

From the news release of the American Association for Justice.

This entry was posted in Medical & Health Resources or Issues. Bookmark the permalink.

Comments are closed.